NEXTCELL PHARMA AB

Share · SE0009723125 · A2DSXP (XSTO)

Overview

No Price

Closing Price XSTO 31.10.2025: 0,90 SEK

31.10.2025 11:59

Current Prices from NEXTCELL PHARMA AB

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ STOCKHOLM AB	NXTCL.ST	SEK	31.10.2025 11:59	0,90 SEK	0,007 SEK +0,78 %

Share Float & Liquidity

Free Float 79,92 %

Shares Float 89,03 M

Shares Outstanding 111,39 M

Company Profile for NEXTCELL PHARMA AB Share

NextCell Pharma AB, a biopharmaceutical company, engages in the research and development of novel stem cell therapies in Sweden. The company develops ProTrans, a drug candidate comprising stem cells primarily for treating autoimmune and inflammatory diseases. It also provides Cellaviva, a stem cell bank for the family-saving of stem cells from umbilical cord blood and umbilical cord tissue. NextCell Pharma AB was incorporated in 2014 and is based in Huddinge, Sweden.

Get up to date insights from finAgent about NEXTCELL PHARMA AB

Company Data

Name NEXTCELL PHARMA AB

Company NextCell Pharma AB

Website https://www.nextcellpharma.com

Primary Exchange

NASDAQ STOCKHOLM AB

WKN A2DSXP

ISIN SE0009723125

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mathias Svahn

Market Capitalization 134 Mio

Country Sweden

Currency SEK

Employees 0,0 T

Address Karolinska Institutet Science Park, 141 57 Huddinge

IPO Date 2017-07-13

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	NXTCL.ST
Frankfurt	65G.F

More Shares

Investors who hold NEXTCELL PHARMA AB also have the following shares in their portfolio:

Hippo Holdings Inc. Common Stock Share

SAUDI ARABIAN OIL COMPANY 2.750% NTS 16/04/22 (RULE 144A) Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog